Comparison of two doses of citrate in regional citrate anticoagulation during hemodialysis

Comparison of biocompatibility markers with two doses of citrate in regional citrate anticoagulation during hemodialysis

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12613001340729

Enrollment

Registered

2013-12-09

Start date

2018-01-12

Completion date

2018-05-21

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To compare markers of biocompatibility with two different doses of citrate in hemodialysis with regional citrate anticoagulation

Interventions

Single, 4 hour hemodialysis with regional citrate anticoagulation with citrate dose 60 mmol/h

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

adult patients, needing hemodialysis

Exclusion criteria

acute illness, acute bleeding, known malignancy, current infection, immunosuppressive or anticoagulant therapy, known intolerance to citrate anticoagulation

Outcome results